Rating Change
Canaccord Genuity analysts reiterated a Buy rating on Hinge Health, Inc. (NYSE:HNGE) on July 21, 2026.
reiterateNYSE:HNGE
Canaccord Genuity Reiterates Buy Rating on Hinge Health, Inc. (HNGE)
Rating Change Canaccord Genuity analysts reiterated a Buy rating on Hinge Health, Inc. (NYSE:HNGE) on July 21, 2026. Market Context Hinge Health, Inc.
Market Context
Hinge Health, Inc. operates in the Healthcare sector. The stock currently trades at $83.99 with a market capitalization of $3.9B.
Analyst coverage from Canaccord Genuity provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Hinge Health, Inc..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Hinge Health, Inc.
Among the 10 most recent ratings: 9 Buy, 1 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 21, 2026 | Canaccord Genuity | Buy | N/A |
| Jul 13, 2026 | Barclays | Overweight | N/A |
| Jul 13, 2026 | Keybanc | Overweight | N/A |
| Jul 13, 2026 | Morgan Stanley | Overweight | N/A |
| Jun 24, 2026 | Wells Fargo | Overweight | N/A |
Related Tools: Analyst Ratings Dashboard | View HNGE Stock Page
Frequently Asked Questions
What does a Buy rating mean for HNGE?
A Buy rating from Canaccord Genuity reflects the analyst's outlook on Hinge Health, Inc. (NYSE:HNGE). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the HNGE forecast page.